Gender differences in prevalence and associated factors of metabolic syndrome in first-treatment and drug-naïve schizophrenia patients

Table 4 Binary logistic regression analyses of determinants of MetS in male and female patients

	Coefficients	Std. error	Wald	p value	95% CI for EXP (B)
	B				Exp(B)	Lower	Upper
Male
TC—mmol/L	2.24	0.84	7.12	0.008*	9.41	1.81	48.87
LDL-C—mmHg	− 1.10	0.85	1.65	0.199	0.33	0.06	1.78
FT₄—pmol/L	− 0.34	0.12	8.12	0.004*	0.72	0.57	0.90
CGI-SI	− 1.13	0.50	5.20	0.023*	0.32	0.12	0.85
Female
Age—years	− 0.16	0.04	20.63	< .001*	0.85	0.79	0.91
TC—mmol/L	1.70	0.29	34.55	< .001*	5.47	3.10	9.64
RBC—10¹²/L	1.89	0.46	16.60	< .001*	6.59	2.66	16.33
WBC—10⁹/L	0.34	0.10	12.38	< .001*	1.40	1.16	1.69
FT₄—pmol/L	− 0.16	0.06	7.06	0.008*	0.85	0.76	0.96
CGI-SI	− 1.57	0.35	20.45	< .001*	0.21	0.11	0.41

TC total cholesterol, LDL-C low-density lipoprotein cholesterol, FT₄ free tetraiodothyronine, CGI-SI Clinical Global Impression Scale—Severity of Illness, TC total cholesterol, RBC red blood cell, WBC white blood cell. *p < 0.05

ISSN: 1744-859X